1-4 of 4
Burgess Freeman
Close
Sort by
Journal Articles

Multiplex CRISPR/Cas9-Based Genome Editing of Mouse Hematopoietic Stem Cells Recapitulates Acute Erythroid Leukemia and Identifies Therapeutic Targets

Ilaria Iacobucci, PhD, Elena Varotto, MD, Chunxu Qu, PhD, Laura Janke, DVM, PhD, Aman Seth, PhD, Anang Shelat, PhD, Burgess Freeman, PhD, James Kennedy, Adam S Sperling, MD PhD, R. Coleman Lindsley, MD PhD, Kirsten Dickerson, BS, Debbie Payne-Turner, Sarah M Morris, Nina Ghosn, Benjamin L. Ebert, MDPhD, Charles G. Mullighan, MBBS, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5.
https://doi.org/10.1182/blood-2018-99-118817
Published: 2018
Journal Articles

PI3K and MEK Inhibition in Hypodiploid Acute Lymphoblastic Leukemia

Evan Comeaux, PhD, Wenwei Lin, PhD, Taosheng Chen, PhD, Burgess Freeman, III, PharmD, Charles G. Mullighan, MBBS, MSc, PhD
Journal: Blood
Blood (2016) 128 (22): 1635.
https://doi.org/10.1182/blood.V128.22.1635.1635
Published: 2016
Journal Articles

A Phase I/II Trial of the KSP Inhibitor ARRY-520 In Relapsed/Refractory Multiple Myeloma

Jatin J Shah, MD, Jeffrey A. Zonder, MD, Adam Cohen, Donna Weber, MD, Sheeba Thomas, MD, Michael Wang, MD, Jonathan L. Kaufman, MD, Steven Michael Burt, Duncan Walker, Burgess Freeman, Selena Armistead Rush, BS, Ann Ptaszynski, Robert Z. Orlowski, MD, PhD, Sagar Lonial, MD
Journal: Blood
Blood (2010) 116 (21): 1959.
https://doi.org/10.1182/blood.V116.21.1959.1959
Published: 2010
Journal Articles

A Phase 1 Dose-Escalation Study of the Novel KSP Inhibitor ARRY-520 in Advanced Leukemias.

Guillermo Garcia-Manero, MD, H. Jean Khoury, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Tapan Kadia, MD, Zeev Estrov, MD, Elias Jabbour, MD, Maria Cielo Foudray, RN, Martha Arellano, Amelia Langston, MD, Beverly Bethelmie-Bryan, Selena Rush, Burgess Freeman, Heidi Simmons, PhD, Mieke Ptaszynski, Hagop Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 2047.
https://doi.org/10.1182/blood.V114.22.2047.2047
Published: 2009